PJP holdings

Holdings

#	Holding	Type	Weight	Value	Shares / par	Country
1	ABBVABBVIE INC.	Equity	5.87%	$32M	116,707	US
2	GILDGilead Sciences Inc	Equity	5.66%	$31M	208,502	US
3	PFEPfizer Inc.	Equity	5.58%	$30M	1,085,738	US
4	LLYEli Lilly & Co.	Equity	5.43%	$29M	25,138	US
5	JNJJohnson & Johnson	Equity	5.38%	$29M	113,567	US
6	AMGNAmgen Inc	Equity	5.26%	$29M	69,974	US
7	MRKMerck & Co., Inc.	Equity	5.21%	$28M	198,279	US
8	ABTAbbott Laboratories	Equity	4.85%	$26M	266,710	US
9	AMRXAmneal Pharmaceuticals, Inc. Class A Common Stock	Equity	3.58%	$19M	986,705	US
10	LGNDLigand Pharmaceuticals Inc.	Equity	3.42%	$19M	62,760	US
11	VTRSViatris Inc. Common Stock	Equity	3.41%	$18M	1,057,526	US
12	UTHRUnited Therapeutics Corp	Equity	3.35%	$18M	34,097	US
13	HRMYHarmony Biosciences Holdings, Inc. Common Stock	Equity	3.32%	$18M	453,965	US
14	TARSTarsus Pharmaceuticals, Inc. Common Stock	Equity	3.30%	$18M	247,475	US
15	PRGOPERRIGO COMPANY PLC	Equity	3.27%	$18M	1,221,121
16	BIIBBiogen Inc. Common Stock	Equity	3.23%	$17M	80,090	US
17	INVAInnoviva, Inc. Common Stock	Equity	3.22%	$17M	835,234	US
18	CORTCorcept Therapeutics Inc.	Equity	3.13%	$17M	143,090	US
19	ANIPANI Pharmaceuticals, Inc.	Equity	3.11%	$17M	233,733	US
20	PBHPrestige Consumer Healthcare Inc.	Equity	3.04%	$16M	343,671	US
21	REGNRegeneron Pharmaceuticals Inc	Equity	2.90%	$16M	21,208	US
22	BMYBristol-Myers Squibb Co.	Equity	2.89%	$16M	260,329	US
23	JAZZJazz Pharmaceuticals, Inc.	Equity	2.79%	$15M	67,947
24	COLLCollegium Pharmaceutical, Inc. Common Stock	Equity	2.63%	$14M	643,677	US
25	TVTXTravere Therapeutics, Inc. Common Stock	Equity	2.54%	$14M	263,866	US
26	OCULOcular Therapeutix, Inc.	Equity	2.25%	$12M	1,625,169	US
27	LQDALiquidia Corporation Common Stock	Equity	1.30%	$7.0M	250,840	US
28	AGPXXInvesco Government & Agency Portfolio	Cash	0.10%	$520K	520,061
29	OmniAb Inc2027-11	Other	0.00%	$0	39,023	US
30	OmniAb Inc2027-11	Other	0.00%	$0	39,023	US
31	SECURITIES LENDING - BNYM	Cash	0.00%	$0	1

Find which other funds hold a stock by opening it and choosing "ETFs holding".

Position changes between reports

Action	Holding	Weight before	Weight after	Shares vs flows	Between reports
Increase	CORTCorcept Therapeutics Inc.	1.43%	3.74%	+134.3%	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	TVTXTravere Therapeutics, Inc.	2.42%	4.00%	+27.5%	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	LGNDLigand Pharmaceuticals Inc.	2.59%	3.56%	+20.4%	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	OCULOcular Therapeutix, Inc.	2.11%	3.07%	+48.6%	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	JAZZJazz Pharmaceuticals PLC	2.54%	3.43%	+14.5%	Jan 31, 2026 → Apr 30, 2026 SEC
Decrease	MRKMerck & Co., Inc.	5.53%	4.67%	−10.9%	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	UTHRUnited Therapeutics Corp.	2.75%	3.54%	+10.7%	Jan 31, 2026 → Apr 30, 2026 SEC
Decrease	VTRSViatris Inc.	3.46%	2.73%	−27.6%	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	COLLCollegium Pharmaceutical, Inc.	2.81%	2.19%	+11.0%	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	HRMYHarmony Biosciences Holdings, Inc.	2.89%	3.25%	+37.6%	Jan 31, 2026 → Apr 30, 2026 SEC
Decrease	BMYBristol-Myers Squibb Co.	3.22%	2.89%	−14.7%	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	TARSTarsus Pharmaceuticals, Inc.	2.19%	2.49%	+20.4%	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	ANIPANI Pharmaceuticals, Inc.	2.82%	3.04%	+16.1%	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	LLYEli Lilly and Co.	4.89%	4.76%	+12.9%	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	ABTAbbott Laboratories	4.33%	4.20%	+22.1%	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	ABBVAbbVie Inc.	4.90%	4.90%	+10.5%	Jan 31, 2026 → Apr 30, 2026 SEC

Share-count changes are measured after removing what creations and redemptions explain.

Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.